| |
The challenges in cancer research are vast. Find a partner who can help you overcome them. With expertise ranging from small dose-finding studies to large multinational trials, we understand how to take an asset from concept to commercialization. Let’s navigate the path. Together.
Premier Research. Built for Biotech℠
|
|
Today's Big NewsJun 2, 2023 |
| By Nick Paul Taylor BioNTech has shared an updated look at the data that persuaded it to gamble $200 million on a rival to Bristol Myers Squibb’s Yervoy. The phase 1/2 study linked the anti-CTLA-4 antibody to a 29.6% response rate, offering encouragement to BioNTech and partner OncoC4 as they gear up for a pivotal clinical trial. |
|
|
|
By James Waldron Oncorus is reducing its head count by 55 people, “representing substantially all" of its workforce. |
By Helen Floersh Developing a new antibiotic can take as long as 15 years. But in as little as two, the target bug can develop resistance to it. Scientists are looking to AI to close the gap. |
By Max Bayer,Annalee Armstrong Eikon has brought on more than a dozen new employees to its clinical development team amid a frenzy of deals. Farallon is victorious at Exelixis' annual shareholder meeting. New Bausch & Lomb CEO rejigs executive group with promotions in the business unit. |
By Teresa Carey This week on "The Top Line," we discuss the need to democratize access to medications like emergency contraception, plus Elizabeth Holmes, the state of Alzheimer's research, and the rest of the week's headlines. |
By Annalee Armstrong Clinical trial platform company Slope is joining the White House’s Cancer Moonshot initiative as a founding member of the public-private partnership CancerX. |
By Andrea Park Where better to find your first-ever chief technology and innovation officer than Big Tech itself? That appears to have been Medtronic’s approach to filling its newest executive position. |
By Angus Liu Novartis has pulled back the curtains on the highly anticipated Kisqali data that previously drove an 8% share-price rally in a single day. As the Swiss pharma aims to bring the CDK4/6 battle with Eli Lilly into earlier treatment of breast cancer, the trial results indicate there's an intense rivalry ahead. |
By Andrea Park In its hunt for the new head of its pharmaceutical systems business—which makes drug delivery devices for 70% of the top 100 drugmakers in the world, according to the company—BD landed on a candidate with plenty of experience among that customer group. |
By Zoey Becker After spinning off from Novartis later this year, generics and biosimilars giant Sandoz plans to move into its new headquarters by the middle of 2024. |
Fierce podcastsDon't miss an episode |
| This week on "The Top Line," we discuss the need to democratize access to medications like emergency contraception, plus Elizabeth Holmes, the state of Alzheimer's research, and the rest of the week's headlines. |
|
|---|
|
|
| eBookSee how clinical trial sponsors can build stronger strategies to address challenges across the patient enrollment funnel, starting with four necessary steps. Sponsored by: OneStudyTeam |
| WhitepaperThis paper outlines various market archetypes and key considerations leaders must address when prioritizing new potential markets for gene therapies. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| WhitepaperChatGPT shows promise in drug discovery for information extraction, scientific text authoring, hypothesis prediction, and chemical entity prediction. This whitepaper explores its potential to streamline research, delving into its technology, applications, and limitations. Sponsored by: Elucidata Corp., Cloud SAAS in Life Sciences R&D |
| WhitepaperLearn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
| WhitepaperThis paper focuses on stakeholder engagement and how Medical Affairs teams’ responsibilities, goals, tools, and techniques are changing. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| ResearchStrategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies Sponsored by: H1 |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| Whitepaper As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs. Sponsored by: Catalent |
| WhitepaperFor sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| WhitepaperDiscover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific. Sponsored by: Catalent |
| WhitepaperHow can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis. Sponsored by: Catalent Clinical Supply |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| WhitepaperPlanning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial. Sponsored by: Catalent |
| |
|
